List of Excipients in API olopatadine hydrochloride and mometasone furoate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olopatadine hydrochloride and mometasone furoate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| HIKMA SPECIALTY USA INC | RYALTRIS | olopatadine hydrochloride and mometasone furoate | 59467-700 | BENZALKONIUM CHLORIDE | 2025-01-13 |
| HIKMA SPECIALTY USA INC | RYALTRIS | olopatadine hydrochloride and mometasone furoate | 59467-700 | CARBOXYMETHYLCELLULOSE SODIUM | 2025-01-13 |
| HIKMA SPECIALTY USA INC | RYALTRIS | olopatadine hydrochloride and mometasone furoate | 59467-700 | CELLULOSE, MICROCRYSTALLINE | 2025-01-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for olopatadine hydrochloride and mometasone furoate
Excipient focus: BENZALKONIUM CHLORIDE
olopatadine hydrochloride and mometasone furoate drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
olopatadine hydrochloride and mometasone furoate drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
olopatadine hydrochloride and mometasone furoate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
olopatadine hydrochloride and mometasone furoate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
olopatadine hydrochloride and mometasone furoate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
olopatadine hydrochloride and mometasone furoate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
olopatadine hydrochloride and mometasone furoate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
olopatadine hydrochloride and mometasone furoate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
olopatadine hydrochloride and mometasone furoate drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
olopatadine hydrochloride and mometasone furoate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| HIKMA SPECIALTY USA INC | olopatadine hydrochloride and mometasone furoate | 59467-700 |
| >Company | >Ingredient | >NDC |
olopatadine hydrochloride and mometasone furoate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch